IL10, interleukin 10, 3586

N. diseases: 1679; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.400 GeneticVariation disease BEFREE Interleukin-10 haplotype associated with total serum IgE in atopic dermatitis patients. 16076299 2005
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.400 Biomarker disease BEFREE Low Interleukin 10 Production at Birth Is a Risk Factor for Atopic Dermatitis in Neonates with Bifidobacterium Colonization. 30205386 2019
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.400 AlteredExpression disease BEFREE Our results showed that ozonated oil could suppress inflammation in an AD murine via decreasing Th2-dominant cytokines response and increasing IL-10 expression. 29466894 2018
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.400 Biomarker disease BEFREE Using intracellular cytokine staining and flow cytometry, the cytokine profile [IL-2, IL-4, IL-10, IL-13, and interferon (IFN)-gamma] of both CD4+ and CD8+ memory/effector T cells circulating in atopic dermatitis (AD) patients was investigated at the single cell level. 9856820 1998
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.400 GeneticVariation disease BEFREE Association between the IL10 -1082A>G (rs1800896) single-nucleotide polymorphism and atopic dermatitis: a systematic review and meta-analysis. 23857017 2014
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.400 AlteredExpression disease BEFREE Mothers who had atopic dermatitis had significantly decreased levels of IL-10 (p = 0.044) in breast milk. 23980846 2013
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.400 Biomarker disease BEFREE IL-10 production was significantly decreased in the supernatants from both the HCs and patients with AD after CRH treatment. 22000570 2012
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic
0.400 GeneticVariation disease BEFREE Polymorphisms in the genes encoding tumour necrosis factor-alpha (TNFA-238 G/A, -308 G/A), interleukin (IL)-1beta (IL1B-511 T/C, +3953 T/C), IL-6 (IL6-174 C/G), IL-10 (IL10-1082 A/G) and the IL-1 receptor antagonist (IL1RN intron 2) were investigated in German patients with AD (n = 94) and in healthy nonatopic individuals (n = 214) by polymerase chain reaction-based methods and direct cycle sequencing. 12828754 2003